Administration of the synthetic FXR agonist GW4064 decreased energy expenditure and accentuated high fat diet induced obesity and glucose intolerance along with decreased BAs pool in mice [44], further supporting a role for BAs in whole body energy regulation. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.